B

BNC Korea Co Ltd
KOSDAQ:256840

Watchlist Manager
BNC Korea Co Ltd
KOSDAQ:256840
Watchlist
Price: 4 610 KRW -2.54% Market Closed
Market Cap: 315.3B KRW

Operating Margin

5.8%
Current
Improving
by 2.3%
vs 3-y average of 3.5%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
5.8%
=
Operating Income
₩5.7B
/
Revenue
₩98.1B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
5.8%
=
Operating Income
₩5.7B
/
Revenue
₩98.1B

Peer Comparison

Country Company Market Cap Operating
Margin
KR
BNC Korea Co Ltd
KOSDAQ:256840
315.3B KRW
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Abbvie Inc
NYSE:ABBV
380.6B USD
Loading...
US
Amgen Inc
NASDAQ:AMGN
182.4B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
158.6B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
116.5B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
77.7B USD
Loading...
AU
CSL Ltd
ASX:CSL
85.3B AUD
Loading...
NL
argenx SE
XBRU:ARGX
42.5B EUR
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
47.5B USD
Loading...
No Stocks Found

Market Distribution

In line with most companies in Korea
Percentile
66th
Based on 2 615 companies
66th percentile
5.8%
Low
-163 055.6% — -2.2%
Typical Range
-2.2% — 6.8%
High
6.8% — 22 874.8%
Distribution Statistics
Korea
Min -163 055.6%
30th Percentile -2.2%
Median 2.7%
70th Percentile 6.8%
Max 22 874.8%

BNC Korea Co Ltd
Glance View

Market Cap
315.3B KRW
Industry
Biotechnology

BNC Korea Co., Ltd. researches and develops strategic application products which include medical devices, pharmaceuticals, and cosmetic products containing physiologically active substances by processing hyaluronic acid and collagen. The company is headquartered in Daegu, Daegu. The company went IPO on 2016-12-28. The firm's main products include hyaluronic acid (HA) fillers, collagen wound dressings, antiadhesion materials and collagen tissue supplements, and others. In addition, the Company produces and sells cosmetics, medicines and medical devices, among others.

Intrinsic Value
4 056.31 KRW
Overvaluation 12%
Intrinsic Value
Price
B
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
5.8%
=
Operating Income
₩5.7B
/
Revenue
₩98.1B
What is BNC Korea Co Ltd's current Operating Margin?

The current Operating Margin for BNC Korea Co Ltd is 5.8%, which is above its 3-year median of 3.5%.

How has Operating Margin changed over time?

Over the last 3 years, BNC Korea Co Ltd’s Operating Margin has increased from -42.6% to 5.8%. During this period, it reached a low of -42.6% on Aug 30, 2022 and a high of 14% on Mar 31, 2024.

Back to Top